Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice

NameINFECTIOUS DISEASES INSTITUTE
Activity TitleNucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice
DetailsJournal club
CompetenceGeneral Medicine
Start Date23-07-2024
End Date23-07-2024
Event Time11:00 AM
LocationHybrid
Cost (UGX)0
CPD Points1